Skip to main content
Fig. 2 | Orphanet Journal of Rare Diseases

Fig. 2

From: Real life data: follow-up assessment on Spanish Gaucher disease patients treated with eliglustat. TRAZELGA project

Fig. 2

Boxplot comparing the classical biomarkers before the switch and after one and two years of treatment. Graphical representation of the mean results for the classical biomarkers before eliglustat treatment and after one and two years A ChT activity; B CCL18/PARC concentration; C GluSph concentration. ChT: Chitotriosidase activity; GluSph: glucosilsphingosine. *p value < 0.05; **p value < 0.01; ***p value < 0.001

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172